Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 132 matching records.
132 results — page 1 of 6
- Level DLaboratory StudyEurope PMC
Brain-derived extracellular vesicles: A promising avenue for Parkinson's disease pathogenesis, diagnosis, and treatment
Laboratory Study on Neuroinflammation, published in Neural Regen Res (2026) — summary generated from the PubMed abstract.
- 2026
Neural Regen Res7 citations - Level DLaboratory StudyPubMed
Therapeutic Effects of Noninvasive Electrical Stimulation in Combination Transplantation of Human Adipose-Derived Stem Cells-Derived Dopaminergic Neuron on the Monkey Model of Parkinson's Disease.
Laboratory Study on Neuroinflammation, Immune Modulation, published in MedComm (2020) (2026) — summary generated from the PubMed abstract.
- 2026
MedComm (2020) - Level DLaboratory StudyEurope PMC
Knockout of the <i>C4BPA</i> Gene Promotes Mitophagy via Activation of the Pink1/Parkin Pathway and Alleviates the Inflammatory Response by Inhibiting the NF-κB Signalling Pathway in Bovine Mammary Epithelial Cells
Laboratory Study on Chronic Inflammation, published in Vet Sci (2026) — summary generated from the PubMed abstract.
- 2026
Vet Sci - Level DAnimal StudyPubMed
Research based on serine metabolism indicates mesenchymal stem cells alleviate psoriasis by regulating the PSPH-PINK1-Parkin-NLRP3 pathway in HaCaT.
Animal Study on Chronic Inflammation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level BClinical TrialEurope PMC
Limitations of Stem Cell Therapy for Parkinson's Disease
Clinical Trial on Neuroinflammation, published in Cells (2026) — summary generated from the PubMed abstract.
- 2026
Cells - Level BRandomized Controlled TrialPubMed
Evaluation of Multiple Intravenous Infusions of Autologous Adipose-Derived Mesenchymal Stem Cells in Parkinson's Disease: A Randomized, Double-Blind Clinical Trial.
Randomized Controlled Trial with a reported sample of 24 on Neuroinflammation, published in Parkinsons Dis (2026) — summary generated from the PubMed abstract.
- 2026
- n = 24
Parkinsons Dis - Level DNarrative ReviewEurope PMC
Induced pluripotent stem cell-derived cardiomyocyte in vitro models: benchmarking progress and ongoing challenges
Narrative Review on Cardiovascular Disease, published in Nat Methods (2025) — summary generated from the PubMed abstract.
- 2025
Nat Methods33 citations - Level DLaboratory StudyEurope PMC
Induced pluripotent stem cell-related approaches to generate dopaminergic neurons for Parkinson's disease
Laboratory Study on Neuroinflammation, published in Neural Regen Res (2025) — summary generated from the PubMed abstract.
- 2025
Neural Regen Res5 citations - Level DAnimal StudyEurope PMC
Human neural stem cell-derived exosomes activate PINK1/Parkin pathway to protect against oxidative stress-induced neuronal injury in ischemic stroke
Animal Study on Stroke Research, published in J Transl Med (2025) — summary generated from the PubMed abstract.
- 2025
J Transl Med24 citations - Level DAnimal StudyPubMed
Small extracellular vesicles from adipose derived stem cells alleviate microglia activation and improve motor deficit of Parkinson's disease via miR-100-5p/DTX3L/STAT1 signaling axis.
Animal Study on Neuroinflammation, Chronic Inflammation, published in Exp Neurol (2025) — summary generated from the PubMed abstract.
- 2025
Exp Neurol3 citations - Level DNarrative ReviewEurope PMC
Challenging glaucoma with emerging therapies: an overview of advancements against the silent thief of sight
Narrative Review, published in Front Med (Lausanne) (2025) — summary generated from the PubMed abstract.
- 2025
Front Med (Lausanne)7 citations - Level DAnimal StudyEurope PMC
Genetically engineered BMSCs promote dopamine secretion and ameliorate motor dysfunction in a Parkinson's disease rat model
Animal Study on Neuroinflammation, published in Sci Rep (2025) — summary generated from the PubMed abstract.
- 2025
Sci Rep2 citations - Level DAnimal StudyEurope PMC
The E3 ligase c-Cbl modulates microglial phenotypes and contributes to Parkinson's disease pathology
Animal Study on Neuroinflammation, published in Cell Death Discov (2025) — summary generated from the PubMed abstract.
- 2025
Cell Death Discov1 citations - Level DAnimal StudyPubMed
Neural-induced human adipose tissue-derived stem cell secretome exerts neuroprotection against rotenone-induced Parkinson's disease in rats.
Animal Study on Neuroinflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther5 citations - Level BClinical TrialEurope PMC
Stem cell therapy for Parkinson's disease: A new hope for neural regeneration
Clinical Trial on Neuroinflammation, published in World J Biol Chem (2025) — summary generated from the PubMed abstract.
- 2025
World J Biol Chem1 citations - Level DAnimal StudyEurope PMC
Tissue Stem Cell-Based Therapies in Parkinson's Disease: A Scoping Review of Therapeutic Mechanisms and Translational Outcomes
Animal Study with a reported sample of 25 on Neuroinflammation, published in Cells (2025) — summary generated from the PubMed abstract.
- 2025
- n = 25
Cells3 citations - Level DAnimal StudyPubMed
Human adipose-derived stem cell exosomes reduce mitochondrial DNA common deletion through PINK1/Parkin-mediated mitophagy to improve skin photoaging.
Animal Study on Skin Aging, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther9 citations - Level DAnimal StudyEurope PMC
PNPLA7 mediates Parkin-mitochondrial recruitment in adipose tissue for mitophagy and inhibits browning
Animal Study, published in Nat Commun (2025) — summary generated from the PubMed abstract.
- 2025
Nat Commun - Level DLaboratory StudyEurope PMC
Complement Receptor 3 Regulates Microglial Exosome Release and Related Neurotoxicity via NADPH Oxidase in Neuroinflammation Associated with Parkinson's Disease
Laboratory Study on Neuroinflammation, published in Antioxidants (Basel) (2025) — summary generated from the PubMed abstract.
- 2025
Antioxidants (Basel)2 citations - Level DAnimal StudyPubMed
Glycyrrhizic acid combined with human adipose-derived MSCs synergistically alleviates the MPP+/MPTP-induced parkinson's disease by inducing autophagy through PI3K/AKT/HIF-1α pathway.
Animal Study on Neuroinflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther5 citations - Level DLaboratory StudyPubMed
Human induced pluripotent stem cell-derived neurons and coculture conditions regulate the adipogenic differentiation and functionality of human adipose stromal/stem cells.
Laboratory Study on Hip, published in Cell Commun Signal (2025) — summary generated from the PubMed abstract.
- 2025
Cell Commun Signal - Level DNarrative ReviewEurope PMC
Microglia in the crosstalk between peripheral and central nervous systems in Parkinson's disease
Narrative Review on Neuroinflammation, Immune Modulation, published in Transl Neurodegener (2025) — summary generated from the PubMed abstract.
- 2025
Transl Neurodegener6 citations - Level DNarrative ReviewEurope PMC
Bridging the gap in Parkinson's disease research: from general pathophysiology to advanced 3d cell culture models
Narrative Review on Neuroinflammation, published in Cell Commun Signal (2025) — summary generated from the PubMed abstract.
- 2025
Cell Commun Signal1 citations - Level BClinical TrialEurope PMC
Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024
Clinical Trial on Neuroinflammation, published in J Mol Med (Berl) (2025) — summary generated from the PubMed abstract.
- 2025
J Mol Med (Berl)2 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406